Normal and delayed wound healing is improved by sesamol, an active constituent of Sesamum indicum (L.) in albino rats

Rekha R. Shenoy, Arun T. Sudheendra, Pawan G. Nayak, Piya Paul, N. Gopalan Kutty, C. Mallikarjuna Rao

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Ethno-pharmacological relevance: The seeds of Sesamum indicum Linn. (Pedaliaceae) has been used traditionally for the treatment of wounds in Buldhana district of Maharashtra state. Sesamol is the main anti-oxidative constituent contained mainly in the processed sesame seed oil which has not been explored scientifically for its wound healing activity. Aim of the study: To investigate the influence of sesamol (SM) on wound repair, both in normal and dexamethasone (DM) delayed healing processes in albino rats. Materials and methods: Incision, excision and dead space wounds were inflicted on albino rats (180-220 g) of either sex, under ketamine anaesthesia. Group I served as control, group II received SM 50 mg/kg i.p.; group III was treated with dexamethasone (DM) i.m. (0.17 mg/kg) and SM + DM was given to group IV. The tensile strength, wound contraction, hydroxyproline, lysyl oxidase and total RNA and DNA levels (in granulation tissue) were measured. Results: The tensile strength significantly (p < 0.05) increased with SM at 471.40 ± 14.66 g when compared to control at 300.60 ± 9.16 g in normal and DM suppressed healing. No significant change was observed in duration of wound contraction and lysyl oxidase when compared to control at 2.98 ± 0.10 mg. SM treated rats showed a significant (p < 0.05) rise in hydroxyproline levels at 6.45 ± 0.45 mg when compared to control at 1.75 ± 0.20 mg. Conclusion: These results indicate that sesamol could be a promising drug in normal as well as delayed wound healing processes.

Original languageEnglish
Pages (from-to)608-612
Number of pages5
JournalJournal of Ethnopharmacology
Volume133
Issue number2
DOIs
Publication statusPublished - 27-01-2011

Fingerprint

Sesamum
Wound Healing
Dexamethasone
Protein-Lysine 6-Oxidase
Wounds and Injuries
Tensile Strength
Pedaliaceae
Seeds
Sesame Oil
Granulation Tissue
Hydroxyproline
Ketamine
sesamol
Anesthesia
Pharmacology
RNA
Control Groups
DNA

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Cite this

@article{69505a1b87ef4caabb69f8f5c7822867,
title = "Normal and delayed wound healing is improved by sesamol, an active constituent of Sesamum indicum (L.) in albino rats",
abstract = "Ethno-pharmacological relevance: The seeds of Sesamum indicum Linn. (Pedaliaceae) has been used traditionally for the treatment of wounds in Buldhana district of Maharashtra state. Sesamol is the main anti-oxidative constituent contained mainly in the processed sesame seed oil which has not been explored scientifically for its wound healing activity. Aim of the study: To investigate the influence of sesamol (SM) on wound repair, both in normal and dexamethasone (DM) delayed healing processes in albino rats. Materials and methods: Incision, excision and dead space wounds were inflicted on albino rats (180-220 g) of either sex, under ketamine anaesthesia. Group I served as control, group II received SM 50 mg/kg i.p.; group III was treated with dexamethasone (DM) i.m. (0.17 mg/kg) and SM + DM was given to group IV. The tensile strength, wound contraction, hydroxyproline, lysyl oxidase and total RNA and DNA levels (in granulation tissue) were measured. Results: The tensile strength significantly (p < 0.05) increased with SM at 471.40 ± 14.66 g when compared to control at 300.60 ± 9.16 g in normal and DM suppressed healing. No significant change was observed in duration of wound contraction and lysyl oxidase when compared to control at 2.98 ± 0.10 mg. SM treated rats showed a significant (p < 0.05) rise in hydroxyproline levels at 6.45 ± 0.45 mg when compared to control at 1.75 ± 0.20 mg. Conclusion: These results indicate that sesamol could be a promising drug in normal as well as delayed wound healing processes.",
author = "Shenoy, {Rekha R.} and Sudheendra, {Arun T.} and Nayak, {Pawan G.} and Piya Paul and Kutty, {N. Gopalan} and Rao, {C. Mallikarjuna}",
year = "2011",
month = "1",
day = "27",
doi = "10.1016/j.jep.2010.10.045",
language = "English",
volume = "133",
pages = "608--612",
journal = "Journal of Ethnopharmacology",
issn = "0378-8741",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

Normal and delayed wound healing is improved by sesamol, an active constituent of Sesamum indicum (L.) in albino rats. / Shenoy, Rekha R.; Sudheendra, Arun T.; Nayak, Pawan G.; Paul, Piya; Kutty, N. Gopalan; Rao, C. Mallikarjuna.

In: Journal of Ethnopharmacology, Vol. 133, No. 2, 27.01.2011, p. 608-612.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Normal and delayed wound healing is improved by sesamol, an active constituent of Sesamum indicum (L.) in albino rats

AU - Shenoy, Rekha R.

AU - Sudheendra, Arun T.

AU - Nayak, Pawan G.

AU - Paul, Piya

AU - Kutty, N. Gopalan

AU - Rao, C. Mallikarjuna

PY - 2011/1/27

Y1 - 2011/1/27

N2 - Ethno-pharmacological relevance: The seeds of Sesamum indicum Linn. (Pedaliaceae) has been used traditionally for the treatment of wounds in Buldhana district of Maharashtra state. Sesamol is the main anti-oxidative constituent contained mainly in the processed sesame seed oil which has not been explored scientifically for its wound healing activity. Aim of the study: To investigate the influence of sesamol (SM) on wound repair, both in normal and dexamethasone (DM) delayed healing processes in albino rats. Materials and methods: Incision, excision and dead space wounds were inflicted on albino rats (180-220 g) of either sex, under ketamine anaesthesia. Group I served as control, group II received SM 50 mg/kg i.p.; group III was treated with dexamethasone (DM) i.m. (0.17 mg/kg) and SM + DM was given to group IV. The tensile strength, wound contraction, hydroxyproline, lysyl oxidase and total RNA and DNA levels (in granulation tissue) were measured. Results: The tensile strength significantly (p < 0.05) increased with SM at 471.40 ± 14.66 g when compared to control at 300.60 ± 9.16 g in normal and DM suppressed healing. No significant change was observed in duration of wound contraction and lysyl oxidase when compared to control at 2.98 ± 0.10 mg. SM treated rats showed a significant (p < 0.05) rise in hydroxyproline levels at 6.45 ± 0.45 mg when compared to control at 1.75 ± 0.20 mg. Conclusion: These results indicate that sesamol could be a promising drug in normal as well as delayed wound healing processes.

AB - Ethno-pharmacological relevance: The seeds of Sesamum indicum Linn. (Pedaliaceae) has been used traditionally for the treatment of wounds in Buldhana district of Maharashtra state. Sesamol is the main anti-oxidative constituent contained mainly in the processed sesame seed oil which has not been explored scientifically for its wound healing activity. Aim of the study: To investigate the influence of sesamol (SM) on wound repair, both in normal and dexamethasone (DM) delayed healing processes in albino rats. Materials and methods: Incision, excision and dead space wounds were inflicted on albino rats (180-220 g) of either sex, under ketamine anaesthesia. Group I served as control, group II received SM 50 mg/kg i.p.; group III was treated with dexamethasone (DM) i.m. (0.17 mg/kg) and SM + DM was given to group IV. The tensile strength, wound contraction, hydroxyproline, lysyl oxidase and total RNA and DNA levels (in granulation tissue) were measured. Results: The tensile strength significantly (p < 0.05) increased with SM at 471.40 ± 14.66 g when compared to control at 300.60 ± 9.16 g in normal and DM suppressed healing. No significant change was observed in duration of wound contraction and lysyl oxidase when compared to control at 2.98 ± 0.10 mg. SM treated rats showed a significant (p < 0.05) rise in hydroxyproline levels at 6.45 ± 0.45 mg when compared to control at 1.75 ± 0.20 mg. Conclusion: These results indicate that sesamol could be a promising drug in normal as well as delayed wound healing processes.

UR - http://www.scopus.com/inward/record.url?scp=78651383357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651383357&partnerID=8YFLogxK

U2 - 10.1016/j.jep.2010.10.045

DO - 10.1016/j.jep.2010.10.045

M3 - Article

C2 - 21035533

AN - SCOPUS:78651383357

VL - 133

SP - 608

EP - 612

JO - Journal of Ethnopharmacology

JF - Journal of Ethnopharmacology

SN - 0378-8741

IS - 2

ER -